@orlucent

Providing Greater Certainty in Mole Evaluation

 Los Gatos, CA
orlucent.com
Joined May 2018
  • Tweets13
  • Following31
  • Followers5
Thank you to Dr. Jonathan Kantor for his May JAAD editorial discussing the recent JAAD International publication of our pivotal clinical trial. We appreciate the discussion of the Orlucent® SFI System’s superior performance compared to dermoscopy. jaad.org/article/S0190-9622(…

In vivo skin fluorescence imaging for dysplastic nevi and melanoma

Recently in JAAD International, Grossman et al1 described their experience with a prospective validation trial using skin fluorescence imaging targeting ανβ3 integrin for detecting melanoma and...

jaad.org
3
Join us at the American Academy of Dermatology Meeting in Denver where Sancy Leachman MD PhD will present our oral poster, #77303 Clinical Utility of Skin Fluorescent Imaging for Melanoma and High-Grade Dysplasia. Friday, March 27 at 2:10 pm in Lobby C Poster Center 2. #AAD2026
29
New innovation alert! The Orlucent® Skin Fluorescent Imaging System was featured in @pspmag in an article titled: Study Finds Noninvasive Imaging Improves Accuracy in Evaluating Suspicious Moles. plasticsurgerypractice.com/c…

Study Finds Noninvasive Imaging Improves Accuracy in Evaluating Suspicious Moles

Clinical trial results show improved diagnostic accuracy with a handheld imaging system used to assess difficult-to-characterize skin moles.

plasticsurgerypractice.com
7
Our appreciation to @ONAcom for providing in-depth trial coverage in the article: Skin Fluorescence Imaging Accurately Flags High-Risk Melanocytic Lesions. We are honored that Dermatology Daily also cited the study as headline news on February 13, 2026. oncologynurseadvisor.com/new…

Skin Fluorescence Imaging Accurately Flags High-Risk Melanocytic Lesions - Oncology Nurse Advisor

This prospective validation study explored the sensitivity and specificity of skin fluorescent imaging in distinguishing high vs low risk melanocytic lesions.

oncologynurseadvisor.com
1
1
38
Many thanks to @InvestorHangout and for authoring the post titled: Revolutionary Imaging System Enhances Melanoma Detection Efforts. investorshangout.com/revolut…

Revolutionary Imaging System Enhances Melanoma Detection Efforts - Investors Hangout

Discover how Orlucent's innovative skin fluorescent imaging system is making strides in non-invasive melanoma detection and improving patient care.

investorshangout.com
1
11
In this interview by The Pathologist CEO Dr. Catherine Shachaf discusses the implications of Orlucent pivotal trial results. Read the post titled Fluorescent Imaging Demystifies Melanoma. thepathologist.com/issues/20…

Fluorescent Imaging Demystifies Melanoma

Study validates non-invasive molecular imaging device for point-of-care assessment of suspicious moles

thepathologist.com
8
We are excited to see Applied Radiology’s coverage of our pivotal clinical trial results in the article titled “Orlucent’s Handheld Imaging Device Shows High Accuracy for Non-Invasive Melanoma Detection.” #SkinCancerDetection #Melanoma #PigmentedLesions appliedradiology.com/article…

Orlucent’s Handheld Imaging Device Shows High Accuracy for Non-Invasive Melanoma Detection |...

Orlucent, Inc. has announced new clinical trial results validating the performance of its Skin Fluorescent Imaging (SFI) System, a non-invasive, handheld…

appliedradiology.com
10
MedTech Outlook recognized Orlucent with a feature article and award for Handheld Fluorescent Molecular Imaging System of the year. Read the article. medicaltechoutlook.com/orluc… #SkinCancerDetection #Melanoma #PigmentedLesions

Orlucent ® | Handheld Fluorescent Molecular Imaging System of the Yea

Orlucent ® has been recognized as Handheld Fluorescent Molecular Imaging System of the Year 2026 by MedTech Outlook Magazine. Orlucent ® delivers the first

medicaltechoutlook.com
11
The Orlucent team has co-authored a review article in Technology in Cancer Research and Treatment which discusses the uses, advantages and limitations of molecular imaging methods employed in the detection of skin cancers. Read the article journals.sagepub.com/doi/10.…

Molecular Imaging in Early Skin Cancer Detection: Advances, Limitations, and Future Directions -...

Early detection of skin cancer is crucial for effective treatment and improved patient outcomes. Recent advancements in oncologic imaging, particularly molecula...

journals.sagepub.com
2
2
120
We are deeply saddened by the passing of Dr. Thomas J. Fogarty, (1934-2025) on December 28, 2025. Dr. Fogarty played a pivotal role in getting Orlucent started, and we will always be grateful for his belief in our mission.
7
We are pleased to announce the results of the Orlucent® pivotal study have been published in the February issue of the Journal of American Academy of Dermatology (JAAD) International. Read the press release. #SkinCancerDetection #Melanoma #PigmentedLesions prnewswire.com/news-releases…
16
Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using First-in-Kind Ha... prn.to/3U2fMNF

Orlucent Demonstrates Accurate, Non-Invasive Detection in vivo of Melanoma-Related Activity Using...

/PRNewswire/ -- In a first-in-human study, researchers at Orlucent, Inc. have demonstrated the viability of a novel handheld point-of-care molecular Skin...

prnewswire.com
37
Orlucent Receives FDA Breakthrough Device Designation for Handheld Mole Imaging System prnewswire.com/news-releases…
33
Load more